Last reviewed · How we verify
NCT05925699: BIG-MENTI
National Database of the Virtual Institute of Cerebrovascular Diseases
trial testing Collection of clinical, radiological, and biological data from patients' medical records in Cerebrovascular Disease in 285,600 participants. Not yet recruiting.
1 September 2052
Quick facts
| Lead sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 285,600 |
| Start date | 1 September 2023 |
| Primary completion | 1 September 2052 |
| Estimated completion | 1 September 2052 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Collection of clinical, radiological, and biological data from patients' medical records
Conditions studied
- Cerebrovascular Disease — all drugs for Cerebrovascular Disease →
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Who can join
Eligibility, any sex, with Cerebrovascular Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary aim of the study is to develop a national registry of cerebrovascular diseases in order to define the subtypes of these diseases associated with a worse prognosis. Secondly, the study aims to find clinical, radiological, and biological markers capable tof predicting the outcome of cerebrovascular diseases and the onset of complications related to therapeutic procedures, and to calculate predictive prognostic scores composed of multiple variables. Each participating center will collect clinical, radiological, and biological data from the medical records of the study participants. Patients included in the study will not undergo any additional medical procedures to those of normal clinical practice.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05925699
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebrovascular Disease
Currently open trials in the same condition.
- NCT07049094 — The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy · Phase 4 · recruiting
- NCT06925178 — Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease · recruiting
- NCT06241482 — Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care · NA · recruiting
- NCT06668519 — Magnetoencephalography in Children · recruiting
- NCT06859502 — National Database of the Virtual Institute of Cerebrovascular Diseases · recruiting
Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials
Trials by the same sponsor.
- NCT07514572 — Impact of Estimated Weight and Height on Nutritional Assessment in Elderly · NA · not yet recruiting
- NCT07504679 — Adipose Visceral and Epicardial Risk Evaluation · NA · not yet recruiting
- NCT07520643 — MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling · not yet recruiting
- NCT07479238 — Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy · not yet recruiting
- NCT07494227 — Development of the SC-IBD Self-Care Measurement Scale · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05925699 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Last refreshed: 13 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05925699.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing